1、Yan DW, Fan JW*, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM,　Peng ZH. . Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. BBA-Mol Basis Dis,2012;1822(6):918-26
2、Han ZB, Chen HY, Fan JW, Wu JY, Tang HM, Peng ZH.. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.. J Cancer Res Clin Oncol., 2012;138(1):153-161.
3、Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ, Peng ZH.. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.. Mol Oncol.,2012;6(4):445-57.
4、Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL.. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.. Ther Drug Monit.,2012; 34(2):126-33.
5、Fan J*, Yan D, Teng M, Tang H, Zhou C, Wang X, Li D, Qiu G, Peng Z.. Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.. Clin Cancer Res,2011;17(9):2908-2918
6、Zhang X, Wang Z, Fan J, Liu G, Peng Z.. Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.. Eur J Clin Pharmacol.,2011;67(8):803-13.
7、Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX, Wang XL, Peng ZH. . Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. . J Cancer Res Clin Oncol.,2010;;136(7):997-1006.
8、Fan J*, Peng Z, Zhou C, Qiu G, Tang H, Sun Y, Wang X, Li Q, Le X, Xie K. . Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.. Cancer,2008;113(2):266-275